Pharma Case Interview: The Complete Prep Guide (2026)

Author: Taylor Warfield, Former Bain Manager and interviewer

Last Updated: April 13, 2026

 

Pharma case interviews are case study exercises used by consulting firms to test how you solve business problems in the pharmaceutical industry. They cover drug pricing, R&D portfolio decisions, market entry for new therapies, and more.

 

If you are interviewing at a firm with a pharma or life sciences practice, there is a strong chance you will get at least one pharma case. In my experience coaching hundreds of candidates at Bain, pharma cases trip people up because they involve unfamiliar terminology and industry-specific dynamics that standard frameworks do not cover.

 

This guide gives you everything you need to ace pharma case interviews: the industry knowledge you must have, the 7 most common pharma case types, a pharma-specific framework, a step-by-step worked example, and practice cases to sharpen your skills.

 

But first, a quick heads up:

 

McKinsey, BCG, Bain, and other top firms accept less than 1% of applicants every year. If you want to triple your chances of landing interviews and 8x your chances of passing them, watch my free 40-minute training.

 

What Is a Pharma Consulting Case Interview?

 

A pharma case interview is a 30 to 45-minute exercise in which you solve a business problem set in the pharmaceutical industry. You work with the interviewer to analyze a situation, structure your thinking, and deliver a recommendation.

 

According to McKinsey, roughly 25% of their global case library draws on healthcare and pharma scenarios. These cases test the same core skills as any consulting case: structured problem solving, quantitative analysis, and clear communication. But they add layers of complexity that other industries do not have.

 

Pharma cases are different from standard consulting cases in several important ways. The table below breaks down the key differences.

 

Dimension

Standard Consulting Cases

Pharma Cases

Stakeholders

Company, customers, competitors

Patients, physicians, payers, regulators, hospitals

Pricing

Cost-plus or competitive pricing

Value-based, payer negotiation, formulary tiers

Regulations

Minimal regulatory focus

FDA approval, patent protection, clinical trial phases

Revenue timeline

Immediate or short-term

10+ years from discovery to first sale

Risk

Market and competitive risk

Clinical failure risk, regulatory rejection, patent cliffs

 

Understanding these differences is the first step to performing well on pharma cases. If you try to apply a generic case interview framework without adapting it for pharma, your analysis will feel shallow to the interviewer.

 

Which Consulting Firms Give Pharma Case Interviews?

 

You can encounter pharma case interviews at two types of firms: generalist strategy firms that have pharma practices and specialist firms that focus exclusively on life sciences and healthcare.

 

Do MBB Firms Give Pharma Cases?

 

Yes. McKinsey, BCG, and Bain all have large healthcare and pharma practices, and they regularly assign pharma cases during interviews. McKinsey even publishes a pharma acquisition case (the GlobaPharm case) as one of their official practice cases on mckinsey.com.

 

At MBB firms, you could get a pharma case even if you are not applying specifically to the healthcare practice. According to Glassdoor, about 15 to 20% of case interviews at MBB involve healthcare or pharma scenarios.

 

Which Specialist Firms Focus on Pharma Cases?

 

If you are interviewing at a life sciences specialist firm, nearly every case you receive will be pharma or biotech related. These firms include:

 

  • ZS Associates

 

  • Putnam (formerly Putnam Associates)

 

  • Clearview Healthcare Partners

 

  • Health Advances

 

  • Trinity Life Sciences

 

  • Simon-Kucher (pharma practice)

 

  • IQVIA Consulting

 

  • LEK Consulting (life sciences practice)

 

For firm-specific prep, check out our guides to the ZS case interview, the Clearview Healthcare case interview, the Putnam case interview, and the Health Advances case interview.

 

What Pharma Industry Knowledge Do You Need?

 

You do not need a science degree to ace pharma case interviews. But you do need to understand three areas well enough to ask smart questions and build a credible framework: the drug development pipeline, drug pricing mechanics, and major industry trends.

 

How Does the Drug Development Pipeline Work?

 

Every prescription drug goes through a multi-stage pipeline before reaching patients. According to the Tufts Center for the Study of Drug Development, bringing a single drug to market costs an average of $2.6 billion and takes 10 to 15 years. Most drug candidates fail along the way.

 

Here are the stages and approximate success rates at each phase, based on data from the FDA and industry research:

 

Stage

Duration

Purpose

Success Rate

Preclinical

3 to 6 years

Lab and animal testing for safety

~5% reach Phase I

Phase I

1 to 2 years

Safety and dosage in small group (20 to 100 people)

~63%

Phase II

1 to 3 years

Efficacy and side effects (100 to 500 people)

~31%

Phase III

2 to 4 years

Large-scale efficacy confirmation (1,000 to 5,000 people)

~58%

FDA Filing/Review

1 to 2 years

Regulatory review for approval

~85%

Commercialization

Ongoing

Launch, marketing, sales

N/A

 

Knowing these stages matters because pharma cases frequently ask you to value a drug pipeline, estimate the probability-weighted revenue of a new drug, or decide whether to invest in advancing a drug to the next phase. You will see these concepts in action in the worked example later in this article.

 

How Does Drug Pricing Work?

 

Drug pricing is more complex than pricing in most other industries because of the multiple stakeholders involved. Unlike a consumer product where the buyer and user are the same person, in pharma, the patient takes the drug, the physician prescribes it, and the payer (insurance company or government) decides whether to cover it and at what level.

 

There are three main approaches to drug pricing that come up repeatedly in pharma case interviews:

 

  • Cost-based pricing: Set the price by adding a target profit margin on top of production and R&D costs. This approach sets a floor price but rarely determines the final price on its own.

 

  • Value-based pricing: Set the price based on the clinical value the drug provides to patients compared to existing treatments. If a drug reduces hospitalizations by 30%, you can quantify that savings and price accordingly.

 

  • Competition-based pricing: Set the price relative to competitor drugs in the same therapeutic area. If three drugs treat the same condition, pricing above or below competitors signals your positioning.

 

In practice, most pharma pricing cases require you to consider all three approaches and find the optimal price point. According to IQVIA data, the average launch price for a new specialty drug in the U.S. exceeded $300,000 per year in 2024, highlighting how pricing decisions involve enormous financial stakes.

 

What Are the Key Pharma Industry Trends?

 

Interviewers expect you to be conversant in major pharma trends. You do not need to be an expert, but mentioning a relevant trend when it connects to the case shows business awareness. Here are the trends most likely to come up:

 

  • Patent cliffs: When a blockbuster drug loses patent protection, generic competitors enter and prices can drop 80% or more within months. According to the Congressional Budget Office, generic entry saves the U.S. healthcare system over $300 billion per year.

 

  • Biologics and biosimilars: Biologic drugs (large-molecule therapies like monoclonal antibodies) now make up over 40% of U.S. drug spending. Biosimilars are the biologic equivalent of generics, but they cost 15 to 35% less rather than 80% less.

 

  • AI in drug discovery: AI tools are reducing early-stage drug discovery timelines by up to 40%, according to McKinsey. This trend appears in cases about R&D productivity and technology investment.

 

  • GLP-1 and obesity drugs: The GLP-1 drug class (Ozempic, Wegovy, Mounjaro) became one of the fastest-growing therapeutic areas in pharma history, reaching over $50 billion in global sales by 2025. Cases about market sizing and competitive dynamics in this space are increasingly common.

 

  • Specialty pharma growth: Specialty drugs that treat complex conditions now account for more than 50% of total U.S. drug spending despite serving less than 2% of patients, according to IQVIA.

 

What Are the 7 Most Common Pharma Case Types?

 

Based on my experience as a Bain interviewer and having reviewed hundreds of candidate debriefs, pharma case interviews tend to fall into seven categories. The table below summarizes each type with a sample prompt.

 

Case Type

What It Tests

Sample Prompt

Drug Pricing

Pricing strategy, payer dynamics, value quantification

Your client has developed a new COPD drug. How should they price it?

R&D Portfolio

Investment prioritization, probability-weighted NPV, pipeline analysis

A pharma company wants to optimize its R&D portfolio. Which projects should it fund?

Pharma M&A

Acquisition valuation, synergies, pipeline assessment

Should GlobaPharm acquire BioFuture, a biologics startup?

Drug Launch

Go-to-market strategy, salesforce deployment, market access

A pharma client is launching a vaccine across Europe. Estimate first-year sales.

Market Sizing

Patient population estimation, treatment rates, revenue forecasting

What is the U.S. market size for a new diabetes drug?

Profitability

Patent cliff impact, generic competition, margin analysis

A pharma company's profits are declining. Identify the cause and fix it.

Salesforce Effectiveness

Territory optimization, physician targeting, ROI analysis

How should a pharma company deploy its sales reps across territories?

 

Drug pricing and M&A cases are the most common types at both MBB and specialist firms. Market sizing cases are especially popular at firms like ZS and Health Advances because they test your ability to estimate patient populations and treatment adoption rates.

 

For a broader look at all case interview types beyond pharma, see our complete guide.

 

If you want to master all seven pharma case types quickly, my case interview course walks you through proven strategies for each case type in as little as 7 days.

 

What Framework Should You Use for Pharma Cases?

 

Standard consulting frameworks work for many industries, but pharma cases need a framework that accounts for clinical risk, regulatory hurdles, and the unique payer landscape. Here is a pharma-specific framework with four buckets that you can adapt to most pharma case types.

 

Bucket 1: Market Opportunity

 

How large and attractive is the market? Explore the patient population size, disease prevalence and incidence rates, treatment rates (what percentage of patients are diagnosed and treated), the market growth rate, and unmet medical needs. For instance, if only 40% of patients with a disease are currently treated, there is significant room for a new drug to capture share.

 

Bucket 2: Clinical and Regulatory Landscape

 

What is the drug's clinical profile and regulatory status? Explore the drug's efficacy compared to existing treatments, its safety profile and side effects, where it sits in the development pipeline (Phase I, II, III, or approved), and the probability of success at each remaining stage. Also consider whether the drug has any regulatory advantages like Breakthrough Therapy or Orphan Drug designation from the FDA, which can accelerate approval.

 

Bucket 3: Competitive and Commercial Strategy

 

How will the drug compete and reach patients? Explore the competitive landscape (how many drugs treat the same condition and at what price), the drug's differentiation and value proposition, the payer landscape (will insurers cover it and at what formulary tier), physician adoption (will doctors switch from existing treatments), and the go-to-market plan including salesforce sizing and marketing strategy.

 

Bucket 4: Financial Viability

 

Will this be a sound financial decision? Explore expected revenues (patient volume multiplied by price), production and commercialization costs, probability-weighted net present value (especially for pipeline drugs), the payback period on R&D investment, and cannibalization risk if the company already sells a competing product.

 

You will not use all four buckets in every pharma case. For a drug pricing case, you might focus heavily on buckets 1 and 3. For an M&A case, all four buckets are critical. The key is to select the most relevant buckets and customize the sub-questions for the specific case you receive.

 

For more on building frameworks from scratch, see our guide to case interview frameworks.

 

How Do You Solve a Pharma Case Interview Step by Step?

 

Let's walk through a full pharma case from start to finish. This worked example is based on a drug pricing scenario similar to cases given at MBB and specialist pharma consulting firms.

 

The Case Prompt

 

Your client is a mid-size pharmaceutical company that has just received FDA approval for a new oncology drug that treats a rare form of lung cancer. There are currently two competing drugs on the market. The client has hired you to recommend a launch price for the drug in the U.S. market.

 

Step 1: Understand the Case and Ask Clarifying Questions

 

First, summarize what you heard back to the interviewer: "Our client has a newly approved oncology drug for a rare lung cancer. Two competitors exist. Our objective is to determine the optimal U.S. launch price. Is that correct?"

 

Then ask targeted clarifying questions. Good examples for this case would be: How does our drug compare clinically to the two competitors? How many patients in the U.S. have this form of lung cancer? Is this a first-line or second-line treatment? What is the dosing regimen?

 

The interviewer tells you: the drug shows a 35% improvement in progression-free survival over Competitor A. About 15,000 patients per year are diagnosed with this cancer in the U.S. The drug is a second-line treatment given as a monthly infusion.

 

Step 2: Structure Your Framework

 

Using the pharma framework above, you might present three buckets tailored to this pricing case:

 

  • Market opportunity: How large is the addressable patient population and what are current treatment rates?

 

  • Competitive and payer landscape: What do competitors charge and how does our drug's clinical value compare? What will payers accept?

 

  • Financial analysis: What are production costs, and what price maximizes revenue while meeting the client's profitability targets?

 

Step 3: Size the Market Opportunity

 

The interviewer provides data: 15,000 new patients per year are diagnosed. About 60% (9,000) progress to second-line treatment. Of those, approximately 70% (6,300) are eligible for infusion-based therapy. This gives you an addressable patient population of 6,300 per year.

 

Step 4: Analyze the Competitive Landscape

 

The interviewer shares: Competitor A charges $12,000 per month and has 65% market share. Competitor B charges $8,000 per month with inferior efficacy and has 35% share. Both drugs require monthly infusions, same as ours.

 

Your drug has a 35% improvement in progression-free survival over Competitor A. This is a meaningful clinical advantage that supports a price premium.

 

Step 5: Determine the Pricing Strategy

 

Now bring the three pricing lenses together. From a cost-based view, the interviewer tells you production costs are $2,000 per dose per month. Any price above this creates positive margin.

 

From a value-based view, the 35% improvement in progression-free survival means patients stay healthier longer and avoid costly hospitalizations. Each avoided hospitalization saves the healthcare system roughly $50,000. If the drug prevents one hospitalization per patient per year on average, you can justify a significant premium over Competitor A's $12,000 monthly price.

 

From a competition-based view, pricing at $14,000 to $16,000 per month would place you above Competitor A (reflecting superior efficacy) while staying within a range that payers are accustomed to for this therapeutic area. You might run a quick calculation: at $15,000 per month and an average treatment duration of 8 months, annual revenue per patient is $120,000. Multiplied by a target of 2,000 patients in year one (roughly 32% of the addressable market), that equals $240 million in first-year revenue.

 

Step 6: Deliver Your Recommendation

 

"I recommend pricing the drug at $15,000 per month for three reasons. First, our drug offers a 35% improvement in progression-free survival, which justifies a premium over the current market leader at $12,000. Second, at $15,000, we achieve strong margins well above our $2,000 production cost. Third, this price point is competitive enough to secure favorable formulary placement with major payers, supporting our target of capturing 32% market share in the first year for roughly $240 million in revenue."

 

"For next steps, I would want to validate the hospitalization cost savings with payer data, test price sensitivity with key physician stakeholders, and model out a 5-year revenue projection including potential generic entry."

 

What Clarifying Questions Should You Ask in Pharma Cases?

 

Asking the right clarifying questions in a pharma case shows the interviewer that you understand the industry. Here are 10 pharma-specific questions organized by category. You would not ask all of these in one case. Pick the 2 to 4 that are most relevant to the case prompt you receive.

 

Disease and Market Questions

 

  • What is the prevalence and incidence of the disease in our target market?

 

  • What percentage of patients are currently diagnosed and treated?

 

  • Is this a chronic or acute condition? How long do patients typically stay on treatment?

 

Drug Characteristics Questions

 

  • How does our drug's efficacy and safety compare to existing treatments?

 

  • What is the dosing regimen and route of administration (oral, injection, infusion)?

 

  • Where is the drug in the development pipeline, and what is the expected approval timeline?

 

Competitive and Payer Questions

 

  • How many competitor drugs are on the market and what do they charge?

 

  • What is the payer mix (commercial insurance vs. Medicare vs. Medicaid)?

 

  • Are there any drugs in the pipeline that could launch as competitors within the next 2 to 3 years?

 

  • Does our client have an existing salesforce and physician relationships in this therapeutic area?

 

What Are the Best Tips for Pharma Case Interviews?

 

Having coached hundreds of candidates through pharma case interviews, here are the six tips that make the biggest difference in performance.

 

Tip 1: Learn the Core Pharma Vocabulary

 

You do not need to know advanced pharmacology. But you must know terms like efficacy, safety profile, clinical trial phases, formulary, payer, indication, and patent expiration. If the interviewer mentions "formulary tier" and you look confused, that is a red flag.

 

Tip 2: Understand the Pharma Value Chain

 

The pharma value chain runs from drug discovery through R&D, manufacturing, regulatory approval, commercial launch, and ongoing sales. Most pharma cases will sit in one or two parts of this chain. Knowing where the case fits will help you ask better questions and build a tighter framework.

 

Tip 3: Practice Pharma-Specific Math

 

Pharma math problems often involve probability-weighted calculations. For example, if a drug has a 30% chance of passing Phase II and a 60% chance of passing Phase III, the combined probability of reaching market from Phase II is 30% multiplied by 60%, which equals 18%. Practice these probability chains and net present value calculations until they feel natural.

 

Tip 4: Do Not Over-Index on Medical Knowledge

 

Consulting firms do not expect you to know the mechanism of action of every drug class. They expect you to think like a business strategist. If the interviewer provides clinical data, interpret it as a business input ("this drug is 35% better, so it justifies a premium"), not as a medical one.

 

Tip 5: Use a Hypothesis-Driven Approach

 

In pharma cases, form a hypothesis early. For a drug pricing case, your hypothesis might be: "I believe we can price at a premium to competitors because our drug has superior clinical outcomes." Then use each analysis step to validate or refine that hypothesis. This keeps the case focused and shows the interviewer you think like a consultant.

 

Tip 6: Practice With Pharma-Specific Cases

 

Generic case practice is valuable, but it is not enough. You need to practice cases that involve drug pipelines, payer dynamics, and clinical data. The next section of this article provides eight practice cases to get you started.

 

If you want personalized feedback on your pharma case performance, my interview coaching sessions can accelerate your prep. You will improve 5x faster than practicing on your own.

 

Pharma Case Interview Practice Cases

 

Below are eight pharma and life sciences case studies that you can use to practice. We recommend working through at least three to four of these before your actual interviews.

 

  • McKinsey GlobaPharm case: An acquisition case focused on whether a large pharma company should acquire a biologics startup. Practice this case.

 

  • ZS COPD drug pricing case: A pricing case focused on determining the optimal price for a new COPD drug. Practice this case.

 

  • Oliver Wyman supermarket pharmacy case: A market entry case evaluating whether a supermarket should open a pharmacy. Practice this case.

 

  • Trinity Life Sciences market entry case: A market entry case for a pharma company choosing between dermatology and ophthalmology. Practice this case.

 

  • LEK baldness cure market sizing case: A market sizing and pricing case for a new baldness treatment. Practice this case.

 

  • Bain coffee company case: While not pharma-specific, this Bain practice case helps you build core case skills. Practice this case.

 

For additional practice beyond pharma cases, see our guide to 100+ case interview examples organized by industry and firm.

 

You can also read our complete guides to healthcare consulting case interviews and life sciences consulting case interviews for even more pharma-related practice material.

 

Frequently Asked Questions

 

Do You Need a Science Background for Pharma Case Interviews?

 

No. Consulting firms hire candidates from all academic backgrounds for pharma consulting roles. What matters is your ability to think structurally about business problems, interpret data, and communicate clearly. Having a science background can be a bonus, but it is not a requirement. In my experience at Bain, some of the best pharma case performers came from liberal arts and economics backgrounds.

 

How Are Pharma Cases Different from Healthcare Cases?

 

Healthcare case interviews cover a broad range of topics including hospitals, insurance, medical devices, and public health. Pharma cases are a subset of healthcare cases that focus specifically on pharmaceutical companies and their challenges: drug pricing, R&D pipelines, drug launches, patent strategy, and salesforce optimization. If you are preparing for a firm with a pharma practice, you should prepare for pharma cases specifically in addition to general healthcare cases.

 

How Long Should You Prepare for Pharma Case Interviews?

 

Plan for at least 4 to 6 weeks of dedicated preparation. During the first week, learn the pharma industry basics covered in this article. In weeks 2 and 3, practice 8 to 10 general cases to build your core case skills. In weeks 4 through 6, focus specifically on pharma cases. According to candidate surveys, the most successful candidates complete 20 to 30 total practice cases before their interviews.

 

What Is the Hardest Part of Pharma Case Interviews?

 

Most candidates struggle with two things. First, the unfamiliar terminology can throw you off if you have not studied it beforehand. Terms like formulary, payer mix, and indication expansion feel foreign if you have no pharma background. Second, the math in pharma cases often involves probability-weighted calculations (like calculating the expected value of a drug pipeline), which is more complex than the basic arithmetic in standard profitability cases.

 

Can You Use Standard Consulting Frameworks for Pharma Cases?

 

You can use standard frameworks as a starting point, but you must adapt them. A generic profitability framework (Revenue minus Costs) will not impress in a pharma case because it misses critical pharma elements like regulatory risk, payer dynamics, and clinical differentiation. Use the pharma-specific framework in this article as your foundation, then customize the sub-bullets for each case you receive.

 

Everything You Need to Land a Consulting Offer

 

Need help passing your interviews?

  • Case Interview Course: Become a top 10% case interview candidate in 7 days while saving yourself 100+ hours

  • Fit Interview Course: Master 98% of consulting fit interview questions in a few hours

  • Interview Coaching: Accelerate your prep with 1-on-1 coaching with Taylor Warfield, former Bain interviewer and best-selling author

  

Need help landing interviews?

 

Need help with everything?

 

Not sure where to start?